254 related articles for article (PubMed ID: 33558678)
41. Safety and tolerability of topiramate and N-acetyl cysteine combination in individuals with alcohol use disorder: a 12 week, randomized, double-blind, pilot study.
Tiouririne NA; Kalelioglu T; Seneviratne C; Wang XQ
Alcohol Alcohol; 2024 Jan; 59(2):. PubMed ID: 38069498
[TBL] [Abstract][Full Text] [Related]
42. Real-time functional magnetic resonance imaging neurofeedback can reduce striatal cue-reactivity to alcohol stimuli.
Kirsch M; Gruber I; Ruf M; Kiefer F; Kirsch P
Addict Biol; 2016 Jul; 21(4):982-92. PubMed ID: 26096546
[TBL] [Abstract][Full Text] [Related]
43. Association of Cortico-Striatal Engagement During Cue Reactivity, Reappraisal, and Savoring of Drug and Non-Drug Stimuli With Craving in Heroin Addiction.
Huang Y; Ceceli AO; Kronberg G; King S; Malaker P; Parvaz MA; Alia-Klein N; Garland EL; Goldstein RZ
Am J Psychiatry; 2024 Feb; 181(2):153-165. PubMed ID: 37434487
[TBL] [Abstract][Full Text] [Related]
44. Effects of naltrexone on adolescent alcohol cue reactivity and sensitivity: an initial randomized trial.
Miranda R; Ray L; Blanchard A; Reynolds EK; Monti PM; Chun T; Justus A; Swift RM; Tidey J; Gwaltney CJ; Ramirez J
Addict Biol; 2014 Sep; 19(5):941-54. PubMed ID: 23489253
[TBL] [Abstract][Full Text] [Related]
45. Functional magnetic resonance imaging (fMRI) response to alcohol pictures predicts subsequent transition to heavy drinking in college students.
Dager AD; Anderson BM; Rosen R; Khadka S; Sawyer B; Jiantonio-Kelly RE; Austad CS; Raskin SA; Tennen H; Wood RM; Fallahi CR; Pearlson GD
Addiction; 2014 Apr; 109(4):585-95. PubMed ID: 24304235
[TBL] [Abstract][Full Text] [Related]
46. The impact of age on olfactory alcohol cue-reactivity: A functional magnetic resonance imaging study in adolescent and adult male drinkers.
Cousijn J; Mies G; Runia N; Derksen M; Willuhn I; Lesscher H
Alcohol Clin Exp Res (Hoboken); 2023 Apr; 47(4):668-677. PubMed ID: 36855285
[TBL] [Abstract][Full Text] [Related]
47. Can't stop the craving: the effect of impulsivity on cue-elicited craving for alcohol in heavy and light social drinkers.
Papachristou H; Nederkoorn C; Havermans R; van der Horst M; Jansen A
Psychopharmacology (Berl); 2012 Jan; 219(2):511-8. PubMed ID: 21384105
[TBL] [Abstract][Full Text] [Related]
48. Clinical and Neural Correlates of Reward and Relief Drinking.
Burnette EM; Grodin EN; Schacht JP; Ray LA
Alcohol Clin Exp Res; 2021 Jan; 45(1):194-203. PubMed ID: 33119924
[TBL] [Abstract][Full Text] [Related]
49. An intensive longitudinal examination of topiramate treatment for alcohol use disorder: a secondary analysis of data from a randomized controlled trial.
Votaw VR; Witkiewitz K; Van Horn ML; Crist RC; Pond T; Kranzler HR
Addiction; 2023 Jun; 118(6):1040-1052. PubMed ID: 36606295
[TBL] [Abstract][Full Text] [Related]
50. Oral topiramate for treatment of alcohol dependence: a randomised controlled trial.
Johnson BA; Ait-Daoud N; Bowden CL; DiClemente CC; Roache JD; Lawson K; Javors MA; Ma JZ
Lancet; 2003 May; 361(9370):1677-85. PubMed ID: 12767733
[TBL] [Abstract][Full Text] [Related]
51. Type A/Type B Alcoholism Predicts Differential Response to Topiramate in a Smoking Cessation Trial in Dually Diagnosed Men.
Isgro M; Doran N; Heffner JL; Wong E; Dinh E; Tibbs J; Russell K; Bittner T; Wehrle C; Worley MJ; Anthenelli RM
J Stud Alcohol Drugs; 2017 Mar; 78(2):232-240. PubMed ID: 28317503
[TBL] [Abstract][Full Text] [Related]
52. Elucidating the Effect of a Brief Drinking Intervention Using Neuroimaging: A Preliminary Study.
Grodin EN; Ray LA; MacKillop J; Lim AC; Karno MP
Alcohol Clin Exp Res; 2019 Feb; 43(2):367-377. PubMed ID: 30556913
[TBL] [Abstract][Full Text] [Related]
53. Topiramate treatment for heavy drinkers: moderation by a GRIK1 polymorphism.
Kranzler HR; Covault J; Feinn R; Armeli S; Tennen H; Arias AJ; Gelernter J; Pond T; Oncken C; Kampman KM
Am J Psychiatry; 2014 Apr; 171(4):445-52. PubMed ID: 24525690
[TBL] [Abstract][Full Text] [Related]
54. Topiramate treatment for alcoholic outpatients recently receiving residential treatment programs: a 12-week, randomized, placebo-controlled trial.
Likhitsathian S; Uttawichai K; Booncharoen H; Wittayanookulluk A; Angkurawaranon C; Srisurapanont M
Drug Alcohol Depend; 2013 Dec; 133(2):440-6. PubMed ID: 23906999
[TBL] [Abstract][Full Text] [Related]
55. The effect of alcohol priming on neural markers of alcohol cue-reactivity.
Courtney KE; Ghahremani DG; Ray LA
Am J Drug Alcohol Abuse; 2015; 41(4):300-8. PubMed ID: 26125586
[TBL] [Abstract][Full Text] [Related]
56. Alcohol Cue-Induced Ventral Striatum Activity Predicts Subsequent Alcohol Self-Administration.
Lim AC; Green R; Grodin EN; Venegas A; Meredith LR; Donato S; Burnette E; Ray LA
Alcohol Clin Exp Res; 2020 Jun; 44(6):1224-1233. PubMed ID: 32406553
[TBL] [Abstract][Full Text] [Related]
57. Neurophysiological effects of modafinil on cue-exposure in cocaine dependence: a randomized placebo-controlled cross-over study using pharmacological fMRI.
Goudriaan AE; Veltman DJ; van den Brink W; Dom G; Schmaal L
Addict Behav; 2013 Feb; 38(2):1509-1517. PubMed ID: 22591950
[TBL] [Abstract][Full Text] [Related]
58. Oxytocin modulates alcohol-cue induced functional connectivity in the nucleus accumbens of social drinkers.
Bach P; Reinhard I; Bühler S; Vollstädt-Klein S; Kiefer F; Koopmann A
Psychoneuroendocrinology; 2019 Nov; 109():104385. PubMed ID: 31362183
[TBL] [Abstract][Full Text] [Related]
59. G-CuP: the effect of a forced oral glucose intake on alcohol craving and mesolimbic cue reactivity in alcohol dependence-study protocol of a randomized, double-blind, placebo-controlled crossover study.
Wetzel L; Pourbaix M; Riegler A; Pfeifer AM; Reinhard I; Hoffmann S; Vollstädt-Klein S; Kiefer F; Sommer W; Bumb JM; Bach P; Koopmann A
Trials; 2022 Aug; 23(1):693. PubMed ID: 35986409
[TBL] [Abstract][Full Text] [Related]
60. Neural substrates of cue reactivity and craving in gambling disorder.
Limbrick-Oldfield EH; Mick I; Cocks RE; McGonigle J; Sharman SP; Goldstone AP; Stokes PR; Waldman A; Erritzoe D; Bowden-Jones H; Nutt D; Lingford-Hughes A; Clark L
Transl Psychiatry; 2017 Jan; 7(1):e992. PubMed ID: 28045460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
